Pola-ZR2P in Previously Untreated DLBCL

Clinical trial NCT06664411 · RECRUITING

Trial details

NCT number: NCT06664411
Sponsor: Navy General Hospital, Beijing
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma

Start date: 2024-09-24
Primary completion: 2029-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.